A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis

Published:2015-02-25 Issue:5 Volume:17 Page:495-504
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Hsiao W.-C.¹,Shia K.-S.¹,Wang Y.-T.¹,Yeh Y.-N.¹,Chang C.-P.¹,Lin Y.¹,Chen P.-H.¹,Wu C.-H.¹,Chao Y.-S.¹,Hung M.-S.¹

Affiliation:

1. Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes; Miaoli Taiwan

Funder

National Health Research Institutes, Taiwan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12447/fullpdf

Reference46 articles.

1. Endocannabinoid control of food intake and energy balance;Di Marzo;Nat Neurosci,2005

2. CB1 antagonists for obesity-what lessons have we learned from rimonabant?;Di Marzo;Nat Rev Endocrinol,2009

3. CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant;Scheen;J Neuroendocrinol,2008

4. The emerging role of the endocannabinoid system in endocrine regulation and energy balance;Pagotto;Endocr Rev,2006

5. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders;Silvestri;Cell Metab,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overactivation of the Endocannabinoid System in Adolescence Disrupts Adult Adipose Organ Function in Mice;Cells;2024-03-06

2. Cannabidiol Nanosystems as a Potential Therapy Targeting Essential Regulators in Metabolic Syndrome;2024

3. Effects of CB1R inverse agonist, INV‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study;Diabetes, Obesity and Metabolism;2023-11-08

4. Changes in plasma endocannabinoids concentrations correlate with 18F-FDG PET/MR uptake in brown adipocytes in humans;Frontiers in Molecular Biosciences;2023-07-26

5. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity;Biomedicines;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3